Amy Flattery
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 16
- Antimicrobial Resistance in Staphylococcus 4
- Clostridium difficile and Clostridium perfringens research 4
- Epidemiology top 2%
- Fungal Infections and Studies 5
- Small Animals top 1%
- Pharmacology top 2%
- Fungal Biology and Applications 7
- Microbial Natural Products and Biosynthesis 4
- Microbiology top 5%
-
- Helicobacter pylori-related gastroenterology studies 5
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- George K. AbruzzoChristopher GillKen BartizalCameron DouglasJeffrey G. SmithV.B. PikounisMartha KurtzL. Kong
- Journals
- Antimicrobial Agents and Chemotherapy (15 papers)Infection and Immunity (3 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesSpainTanzania
In The Last Decade
Amy Flattery
37 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 92
- Infectious Diseases 1.8k
- Epidemiology 1.2k
- Small Animals 247
- Pharmacology 495
- Microbiology 82
Countries citing papers authored by Amy Flattery
This map shows the geographic impact of Amy Flattery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Flattery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Flattery more than expected).
Fields of papers citing papers by Amy Flattery
This network shows the impact of papers produced by Amy Flattery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Flattery. The network helps show where Amy Flattery may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Flattery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2017 | 72 | |
| 3 | 2016 | 27 | |
| 4 | 2014 | 65 | |
| 5 | 2011 | 10 | |
| 6 | 2011 | 11 | |
| 7 | 2011 | 8 | |
| 8 | 2007 | 9 | |
| 9 | 2003 | 68 | |
| 10 | 2001 | 183 | |
| 11 | 2001 | 32 | |
| 12 | 2001 | 32 | |
| 13 | 2000 | 110 | |
| 14 | 1998 | 97 | |
| 15 | 1997 | 6 | |
| 16 | 1997 | 262 | |
| 17 | 1996 | 13 | |
| 18 | 1995 | 6 | |
| 19 | 1995 | 67 | |
| 20 | Up-regulation of gene expression by FK 506. | 1991 | 3 |
About Amy Flattery
Amy Flattery is a scholar working on Infectious Diseases, Small Animals and Pharmacology, having authored 37 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (16 papers), Fungal Biology and Applications (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Fungal Infections and Studies (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Epidemiology (1.2k citations) and Small Animals (247 citations). Amy Flattery has collaborated with scholars based in United States, Spain and Tanzania. Frequent co-authors include George K. Abruzzo, Christopher Gill, Ken Bartizal, Cameron Douglas, Jeffrey G. Smith, V.B. Pikounis, Martha Kurtz, L. Kong, Charles Gill and James M. Balkovec. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity, Journal of Biological Chemistry, Journal of Cardiovascular Translational Research and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.